AstraZeneca to strike landmark drug price deal with Trump administration
.webp)
AstraZeneca PLC is expected to announce a deal with President Donald Trump to slash drug prices, people familiar with the plans said, making it the second pharmaceutical company to strike an agreement to advance one of Trump’s key health priorities.
While details about the pact weren’t immediately clear, the accord stems from a major push by the administration to lower drug prices in the US and ensure other wealthy countries shoulder a larger share of the cost of developing breakthrough new medicines.
The deal is expected to be announced at the White House on Friday, said the people, who spoke on condition of anonymity because the plans are not yet public.
AstraZeneca and the White House declined to provide a comment.
Pfizer Inc. was first out of the gate in late September. It agreed to slash some drug prices by as much as 85% and sell them directly to the public in exchange for a three-year reprieve from the tariffs that Trump has threatened since the start of his second term.
MSNBC reported the agreement earlier on Friday.
Other Latest News
.webp)
Tourist visits in Uttar Pradesh surged by 43.4 crore between 2016 and 2023. UP Chief Minister Yogi Adityanath said that 21.5 crore tourists visited in 2016, this number has surged to 64.9 crore by 2024. From the perspective of national tourism, Uttar Pradesh's share was 13.1 per cent in 2016, which has increased to 18.9 per cent by 2023.
In a Tweet on X, the UP CM said, "Under the guidance of the esteemed Prime Minister @narendramodi ji, the new Uttar Pradesh has today become an inspiration for the nation, transforming through tourism.
.webp)
The Bombay High Court has granted an interim stay in a case challenging the higher Goods and Services Tax (GST) rate of 18 per cent levied on restaurants operating within premium hotels, compared to 5 per cent for standalone restaurants, according to a report by The Economic Times.
The matter will be heard next on November 19. According to the report, the High Court has also issued notices to the Centre, the Maharashtra government, the GST Council, and other state authorities.
.webp)
JM Financial downgraded the stock of InterGlobe Aviation (IndiGo) to 'Reduce', citing that an increased fuel cost and weak rupee are expected to "adversely" impact its second-quarter earnings.
The brokerage cut the rating to 'Reduce' from 'Hold' with a target price of ₹5,570 per share, a downside of 2.8 per cent from Friday's close.
.webp)
The United Forum of Bank Unions (UFBU), representing nine unions of officers and workmen across public sector banks (PSBs) on Friday strongly opposed the Centre’s recent move to open up top management positions in PSBs, the Life Insurance Corporation of India (LIC), and non-life insurance companies to private sector candidates. Calling it “an attack on the public character of national institutions”, the UFBU has demanded immediate withdrawal of the revised consolidated guidelines issued by the Appointments Committee of the Cabinet (ACC).
.webp)
Amid developments within Tata Trusts, the Shapoorji Pallonji (SP) group, which owns an 18.4 per cent stake in Tata Sons, said it was “both timely and necessary” to reiterate its longstanding position of listing Tata Sons — a stand rooted in transparency, fairness, public interest, and adherence to good corporate governance.
In a statement, the SP group expressed full faith in the Reserve Bank of India (RBI), describing it as a constitutional and autonomous body guided by the principles of equity, justice, and public interest.
.webp)
.webp)
.webp)
.webp)
.webp)
